Emini is Vice President of Vaccine and Antiviral Research at the Merck Research Laboratories. He led the biological basic research team that developed indinavir, one of the first HIV protease inhibitors. He holds a PhD in virology from Cornell University's Graduate School of Medicine Sciences.